<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-9190</journal-id>
<journal-title><![CDATA[Revista alergia México]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. alerg. Méx.]]></abbrev-journal-title>
<issn>2448-9190</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Inmunología Clínica y Alergia A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-91902019000100027</article-id>
<article-id pub-id-type="doi">10.29262/ram.v66i1.531</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Extractos dializados de leucocitos para el tratamiento de infecciones recurrentes y severas en pacientes pediátricos con inmunodeficiencia celular: 15 años de experiencia]]></article-title>
<article-title xml:lang="en"><![CDATA[Dialyzed leukocyte extracts for the treatment of recurrent and severe infections in pediatric patients with cellular immunodeficiency: 15 years of experience]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ayala]]></surname>
<given-names><![CDATA[María del Carmen]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[Nancy María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Palacios]]></surname>
<given-names><![CDATA[Gerardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rivera-Morales]]></surname>
<given-names><![CDATA[Lydia Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Padilla]]></surname>
<given-names><![CDATA[Cristina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Especialidades 25 Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[ Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma de Nuevo León Facultad de Ciencias Biológicas Departamento de Microbiología e Inmunología]]></institution>
<addr-line><![CDATA[ Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<volume>66</volume>
<numero>1</numero>
<fpage>27</fpage>
<lpage>37</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-91902019000100027&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-91902019000100027&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-91902019000100027&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Antecedentes:  Los extractos dializados de leucocitos (EDL) han sido utilizados en el tratamiento de diversos defectos de la inmunidad celular.  Objetivo:  Revisar la experiencia en el uso de EDL para tratar infecciones recurrentes o severas en niños con inmunodeficiencia celular adquirida no debida a virus de la inmunodeficiencia oportuna.  Métodos:  Se revisaron expedientes de niños tratados con EDL humano o bovino entre 1986 y 2000, por infecciones recurrentes o severas sin respuesta a antimicrobianos y con déficit en la respuesta inmune celular. La dosis se ajustó por el porcentaje de poblaciones de linfocitos T. En el seguimiento a cinco años, la respuesta inmune se evaluó por subpoblaciones de linfocitos, intradermorreacción e inhibición de la migración de leucocitos (LIF) a PPD, coccidioidina, varidasa y candidina.  Resultados:  150 niños recibieron EDL, edad 7.0 ± 5.9 años. Las indicaciones más frecuentes incluyeron infección respiratoria superior (71 %), respiratoria inferior (43 %), gastrointestinal (15 %), urinaria (15 %), neuroinfección (4 %) y coccidioidomicosis (3 %). Se incrementaron los linfocitos T, el LIF a PPD y varidasa (&gt; 20 %), así como la induración en pruebas de intradermorreacción (p &lt; 0.001). Se resolvieron las infecciones que se presentaron (4 %). No se reportaron efectos adversos.  Conclusiones:  El uso de EDL mejoró los parámetros inmunológicos y la evolución clínica en niños con déficit inmune celular.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background:  Dialyzable leukocyte extracts (DLE) have been used to treat several cellular immunodeficiency.  Objective:  To review the experience of a tertiary hospital in the use of DLE for the treatment of recurrent or severe infections in children with acquired cellular immunodeficiency not due to HIV.  Methods:  We reviewed the medical records of all children who received treatment with EDL of human or bovine origin between 1986 and 2000 to detect recurrent or severe infections without response to a specific antimicrobial therapy and with a quantitative or qualitative deficit in the cellular immune response. The dose of DLE was adjusted according to the percentage of T lymphocytes; the evolution of the patient was evaluated retrospectively for 5 years, the immune response was evaluated by subpopulation of lymphocytes and intradermal tests and inhibition of the leukocyte migration assay (LIF) to PPD, coccidioidin, varidase and candidin.  Results:  150 children received DLE, age 7.0 ± 5.9 years. The most frequent indications included upper respiratory tract (71%), lower respiratory tract (43%), gastrointestinal tract (15%), urinary tract (15%) and neurological infections (4%) and coccidioidomycosis (3%). After starting the DLE, the numbers of T lymphocytes, LIF to PPD and varidase (&gt; 20%) and the intradermal induration of the test increased (p &lt;0.001). In 6 patients (4%) recurrences of respiratory and gastrointestinal tract infections were observed, which resolved, no adverse effects attributable to the DLE were reported.  Conclusions:  The use of DLE for recurrent or severe infectious processes in children with cellular immune deficit improved the clinical evolution and the immunological parameters evaluated without adverse effects attributable to their use.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Inmunodeficiencia celular]]></kwd>
<kwd lng="es"><![CDATA[Extractos dializados de leucocitos]]></kwd>
<kwd lng="es"><![CDATA[Factores de transferencia]]></kwd>
<kwd lng="es"><![CDATA[Inmunomoduladores]]></kwd>
<kwd lng="en"><![CDATA[Cellular immunodeficiency]]></kwd>
<kwd lng="en"><![CDATA[Extracted dialyzable leukocytes]]></kwd>
<kwd lng="en"><![CDATA[Transfer factors]]></kwd>
<kwd lng="en"><![CDATA[Immunomodulatory]]></kwd>
<kwd lng="en"><![CDATA[Immunotherapy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lawrence]]></surname>
<given-names><![CDATA[HS.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The cellular transfer of cutaneous hypersensitivity to tuberculin in man]]></article-title>
<source><![CDATA[Proc Soc Exp Biol Med.]]></source>
<year>1949</year>
<volume>71</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>516-22</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salazar-Villa]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Mejía-Ortega]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso del factor de transferencia en el asma bronquial alérgica]]></article-title>
<source><![CDATA[Rev Alerg Mex.]]></source>
<year>1993</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>42-5</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdés-Sánchez]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Ortega]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Echeverría]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Gillama-Niebla]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lastra-Alfonso]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[López-Saura]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dermatitis atópica. Tratamiento con factor de transferencia. Ensayo clínico controlado.]]></article-title>
<source><![CDATA[Rev Alerg Mex.]]></source>
<year>1991</year>
<volume>38</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>158-62</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abramson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tate]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[NO.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunocompetence and transfer factor therapy in uveitis.]]></article-title>
<source><![CDATA[Br J Opthalmol]]></source>
<year>1980</year>
<volume>64</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>332-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dwyer]]></surname>
<given-names><![CDATA[JM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transfer factor in the age of molecular biology: a review]]></article-title>
<source><![CDATA[Biotherapy]]></source>
<year>1996</year>
<volume>9</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>7-11</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lawrence]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Borkowsky]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transfer factor: current status and future prospects.]]></article-title>
<source><![CDATA[Biotherapy]]></source>
<year>1996</year>
<volume>9</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steele]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Vincent]]></surname>
<given-names><![CDATA[MM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transfer factor for the prevention of varicella-Zoster infection in childhood leukemia.]]></article-title>
<source><![CDATA[New Engl J Med.]]></source>
<year>1980</year>
<volume>303</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>335-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez-González]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa-Luna]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Vásquez-Moctezuma]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de transferencia en la terapéutica médica.]]></article-title>
<source><![CDATA[Med Clin]]></source>
<year>2011</year>
<volume>137</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>273-7</page-range><publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cruz-Barrios]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Montiel]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
<name>
<surname><![CDATA[Furones-Mourrelle]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Martín-De la Riva]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Guerra-Suárez]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Páez-Pérez]]></surname>
<given-names><![CDATA[AT.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patrones de prescripción del factor de transferencia en 11 hospitales de ciudad de la Habana, 2002.]]></article-title>
<source><![CDATA[Rev Cubana Salud Pub.]]></source>
<year>2005</year>
<volume>31</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>291-5</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Torres]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes-Ruiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Benítez-Londoño]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Franco-Molina]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Padilla]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunepotent CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production]]></article-title>
<source><![CDATA[BMC Cancer.]]></source>
<year>2018</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Cao]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sha]]></surname>
<given-names><![CDATA[ZH]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interventions for preventing infection in nephritic syndrome.]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev.]]></source>
<year>2012</year>
<numero>4</numero>
<issue>4</issue>
<page-range>CD003964</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez-Vera]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez-Sánchez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Flores-Sandoval]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factor de transferencia y alergia.]]></article-title>
<source><![CDATA[Rev Alerg Mex.]]></source>
<year>2010</year>
<numero>57</numero>
<issue>57</issue>
<page-range>220-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navarro-Cruz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano-Miranda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Orea-Solano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factor de transferencia en dermatitis atópica moderada y severa]]></article-title>
<source><![CDATA[Rev Alerg Mex.]]></source>
<year>1996</year>
<volume>43</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>116-23</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coronado-Cerda]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Franco-Molina]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Gamboa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Prado-García]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera-Morales]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata-Benavides]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In vivo chemoprotective activity of bovine dialyzable leukocyte extract in mouse bone marrow cells against damage induced by 5-Fluorouracil]]></article-title>
<source><![CDATA[J Immunol Res.]]></source>
<year>2016</year>
<numero>2016</numero>
<issue>2016</issue>
<page-range>6942321</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franco-Molina]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Gamboa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata-Benavides]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vera-García]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo-Tello]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[García-De-La-Fuente]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunepotent CRP (bovine dialyzable leukocyte extract) adjuvant immunotherapy: a phase I study in non-small cell lung cancer patients.]]></article-title>
<source><![CDATA[Cytotherapy]]></source>
<year>2008</year>
<volume>10</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>490-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franco-Molina]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Gamboa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda-Hernández]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra-Rivera]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata-Benavides]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vera-García]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anti-inflammatory and antioxidant effects of Immunepotent CRP in lipopolysaccharide (LPS)-stimulated human macrophages.]]></article-title>
<source><![CDATA[Afr J Microbiol Res.]]></source>
<year>2011</year>
<numero>5</numero>
<issue>5</issue>
<page-range>3726-36</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Salazar]]></surname>
<given-names><![CDATA[MDC]]></given-names>
</name>
<name>
<surname><![CDATA[Franco-Molina]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Gamboa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Torres]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata-Benavides]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[López-González]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The novel immunomodulator Immunepotent CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth]]></article-title>
<source><![CDATA[Oncol Lett.]]></source>
<year>2017</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>844-52</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lawrence]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Askari]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The preparation and purification of transfer factor]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Bloom]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Glade]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
</person-group>
<source><![CDATA[In vitro methods in cell mediated immunity]]></source>
<year>1971</year>
<publisher-loc><![CDATA[EE. UU. ]]></publisher-loc>
<publisher-name><![CDATA[Academic Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cavazos-Cavazos]]></surname>
<given-names><![CDATA[AM.]]></given-names>
</name>
</person-group>
<source><![CDATA[Inmunoterapia con factor de transferencia en pacientes con coccidiodomicosis]]></source>
<year>1989</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Autónoma de Nuevo León]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hannet]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Erkeller-Yuksel]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lydyard]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Deneys]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[DeBruyère]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Developmental and maturational changes in human blood lymphocyte subpopulations.]]></article-title>
<source><![CDATA[Immunol Today.]]></source>
<year>1992</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>215-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shearer]]></surname>
<given-names><![CDATA[WT.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Monitoring cellular immune function in HIV infection by the delayed hypersensitivity skin test: alternative to the CD4 T-cell count?]]></article-title>
<source><![CDATA[J Allergy Clin Immunol.]]></source>
<year>1999</year>
<volume>103</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalish]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Askenasa]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular mechanism of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma and autoimmunity]]></article-title>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>1999</year>
<volume>103</volume>
<page-range>192-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borkowsky]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Lawrence]]></surname>
<given-names><![CDATA[HS.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of human leukocyte dialyzable containing transfer factor in the direct leukocyte migration inhibition (LMI) assay]]></article-title>
<source><![CDATA[J Immunol.]]></source>
<year>1979</year>
<volume>123</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1741-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gerbase-DeLima]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carlquist]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes]]></surname>
<given-names><![CDATA[NF.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Specificity of the local transfer of cell-mediated immunity with dialyzable transfer factor]]></article-title>
<source><![CDATA[Cell Immunol.]]></source>
<year>1979</year>
<volume>48</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>231-4</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirkpatrick]]></surname>
<given-names><![CDATA[CH.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transfer factors: identification of conserved sequences in transfer factor molecules]]></article-title>
<source><![CDATA[Mol Med.]]></source>
<year>2000</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>332-41</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hadden]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunopharmacology: immunomodulation and immunotherapy]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1987</year>
<volume>258</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>2008-17</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Estrada-Parra]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez-Sánchez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ondarza-Aguilera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Correa-Meza]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano-Miranda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Monges-Nicolau]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunotherapy with transfer factor of recurrent herpes simplex type I.]]></article-title>
<source><![CDATA[Arch Med Res.]]></source>
<year>1995</year>
<volume>26</volume>
<page-range>S87-92</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pizza]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Viza]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[De Vinci]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Palareti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cuzzocrea]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fornarola]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses]]></article-title>
<source><![CDATA[Biotherapy]]></source>
<year>1996</year>
<volume>9</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>67-72</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirkpatrick]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Hamond]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Morton]]></surname>
<given-names><![CDATA[LC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Murine transfer factors: dose-response relationships and routes of administration.]]></article-title>
<source><![CDATA[Cell Immunol.]]></source>
<year>1995</year>
<volume>164</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>203-6</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cid-Chávez]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Pedraza]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Sánchez]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Staines-Boone]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Castro-Pineda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Palacios-Saucedo]]></surname>
<given-names><![CDATA[GD.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínicas e inmunológicas en pacientes pediátricos con coccidioidomicosis en el noreste de México]]></article-title>
<source><![CDATA[Gac Med Mex.]]></source>
<year>2013</year>
<volume>149</volume>
<page-range>541-7</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirkpatrick]]></surname>
<given-names><![CDATA[CH.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Activities and characteristics of transfer factors.]]></article-title>
<source><![CDATA[Biotherapy]]></source>
<year>1996</year>
<volume>9</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>13-6</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fudenberg]]></surname>
<given-names><![CDATA[HH.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study.]]></article-title>
<source><![CDATA[Biotherapy]]></source>
<year>1996</year>
<volume>9</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>143-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
